Herpes HSV 1 & 2 PCR Lab Test in Lahore at Chughtai Lab
Book at Chughtai Lab · Lahore, Pakistan
Book this test
Herpes (HSV 1 & 2) PCR (Qualitative) at Chughtai Lab
The Herpes Simplex Virus (HSV) is a highly prevalent double-stranded DNA virus belonging to the Herpesviridae family. It is classified into two distinct serotypes: Herpes Simplex Virus Type 1 (HSV-1) and Herpes Simplex Virus Type 2 (HSV-2). While HSV-1 is traditionally associated with orolabial lesions (cold sores) and HSV-2 with genital infections, clinical epidemiology shows significant overlap, with HSV-1 increasingly identified in primary genital infections. The Herpes (HSV 1 & 2) PCR (Qualitative) test at Chughtai Lab is an advanced molecular diagnostic assay designed to detect and differentiate the genetic material (DNA) of both viral types with exceptional sensitivity and specificity.
Polymerase Chain Reaction (PCR) technology represents the gold standard in molecular diagnostics. Unlike traditional viral culture methods, which require viable replicating viruses and can take several days to yield results, PCR amplifies specific target DNA sequences of the virus. This allows for the detection of extremely low viral loads, even in healing lesions or in asymptomatic patients experiencing viral shedding. Qualitative PCR provides a definitive “Detected” or “Not Detected” result for each serotype, enabling clinicians to establish an accurate diagnosis, initiate targeted antiviral therapy, and implement appropriate patient counseling to prevent transmission.
The clinical utility of this molecular assay is profound. It evaluates specific anatomical sites where active viral replication is suspected, including the oral mucosa, genital tract, skin, eyes, and, in severe cases, the central nervous system via cerebrospinal fluid (CSF). Accurate differentiation between HSV-1 and HSV-2 is vital because the prognosis, recurrence rates, and long-term management strategies differ significantly between the two serotypes. For instance, genital HSV-2 infections are associated with a much higher rate of recurrent outbreaks and subclinical shedding compared to genital HSV-1 infections.
Clinical Procedure: What to Expect
Patient Preparation
Proper patient preparation is essential to ensure specimen integrity and avoid false-negative results. Patients undergoing the Herpes (HSV 1 & 2) PCR (Qualitative) test at Chughtai Lab should adhere to the following guidelines:
- Avoid Topical Applications: Do not apply any topical creams, ointments, antiviral agents, or powders to the active lesions for at least 24 hours prior to sample collection, as these substances can interfere with the PCR assay.
- Disclose Medications: Inform the healthcare provider and lab staff of any systemic antiviral medications (such as acyclovir, valacyclovir, or famciclovir) currently being taken, as these can suppress viral replication and potentially lead to a false-negative result.
- Timing of Collection: For lesion swabs, the sample should ideally be collected during the early vesicular stage of an outbreak when viral load is at its peak. Healing or crusted lesions contain significantly less viral DNA.
- No Fasting Required: There are no dietary restrictions or fasting requirements for this test, whether the sample is a swab, blood, or cerebrospinal fluid.
During the Procedure
The sample collection process depends on the clinical presentation and the specific source of the suspected infection. Chughtai Lab utilizes standardized, sterile protocols to ensure patient comfort and sample quality:
- Lesion Swab Collection: If active vesicles are present, a trained phlebotomist or clinician will gently unroof a fresh vesicle using a sterile needle or swab. They will then vigorously swab the base of the lesion to collect epithelial cells, as HSV is an intracellular pathogen. This process may cause mild, temporary discomfort.
- Blood Sample Collection: For suspected systemic or neonatal infections, a standard venipuncture is performed. A small volume of blood is drawn from a vein in the arm into a sterile tube.
- Cerebrospinal Fluid (CSF) Collection: In cases of suspected herpes simplex encephalitis or meningitis, a lumbar puncture is performed by a qualified physician in a clinical or hospital setting. The collected CSF is immediately transported to the molecular laboratory.
- Safety and Hygiene: All procedures are conducted using sterile, single-use equipment under strict aseptic conditions to eliminate any risk of cross-contamination.
When is a Herpes (HSV 1 & 2) PCR (Qualitative) Performed?
Diagnosis of Active Genital Ulcers
Physicians request this test when a patient presents with painful genital ulcers, vesicles, or erosions. Because clinical presentation alone cannot reliably distinguish HSV from other ulcerative sexually transmitted infections (such as syphilis or chancroid), PCR is utilized to provide a definitive molecular diagnosis, allowing for prompt and specific antiviral intervention.
Evaluation of Oral Lesions and Cold Sores
In cases of severe, atypical, or recurrent oral ulcerations, clinicians perform an HSV PCR test to confirm the diagnosis. This is particularly important in pediatric patients experiencing severe primary herpetic gingivostomatitis or in individuals where the clinical presentation mimics aphthous ulcers or erythema multiforme.
Screening and Prevention of Neonatal Herpes
Pregnant women with a history of genital herpes or those presenting with active genital lesions near the time of delivery are closely monitored using HSV PCR. Neonatal herpes, acquired during passage through an infected birth canal, is a catastrophic condition that can lead to severe neurological damage or systemic multi-organ failure. Rapid PCR testing helps obstetricians decide between a vaginal delivery and a cesarean section.
Investigation of Suspected Viral Encephalitis or Meningitis
Herpes Simplex Encephalitis (HSE) is a medical emergency with high mortality if untreated. It is primarily caused by HSV-1, whereas HSV-2 is more frequently associated with benign recurrent lymphocytic meningitis (Mollaret's meningitis). When a patient presents with fever, altered mental status, focal neurological deficits, or meningeal signs, a CSF PCR for HSV-1 and HSV-2 is urgently performed to guide immediate intravenous antiviral therapy.
Management of Immunocompromised Patients
In patients with compromised immune systems, such as those with HIV/AIDS, patients undergoing chemotherapy, or transplant recipients, HSV infections can present atypically, cover extensive anatomical areas, and lead to chronic, non-healing ulcers. PCR testing is critical in these scenarios to confirm HSV etiology and monitor for potential treatment failure or drug resistance.
What Does a Herpes (HSV 1 & 2) PCR (Qualitative) Detect?
The qualitative PCR assay is designed to detect specific molecular targets within the viral genome. It identifies and differentiates the following clinical findings and states:
- Presence of Herpes Simplex Virus Type 1 (HSV-1) viral DNA in the analyzed specimen.
- Presence of Herpes Simplex Virus Type 2 (HSV-2) viral DNA in the analyzed specimen.
- Absence of both HSV-1 and HSV-2 viral DNA, indicating no active viral shedding at the sampled site.
- Active primary orolabial herpes infection.
- Recurrent HSV-1 outbreaks in oral or perioral regions.
- Active primary genital herpes infection caused by HSV-2.
- Active primary genital herpes infection caused by HSV-1.
- Recurrent genital herpes outbreaks.
- Asymptomatic or subclinical viral shedding in mucosal secretions.
- Herpes Simplex Encephalitis (HSE) via detection of HSV-1 DNA in cerebrospinal fluid.
- Herpes Simplex Meningitis via detection of HSV-2 DNA in cerebrospinal fluid.
- Neonatal herpes simplex virus infection in neonatal blood or surface swabs.
- Herpetic Keratitis (ocular herpes) via corneal or conjunctival swab analysis.
- Herpetic Whitlow, an HSV infection of the fingers or hand.
- Eczema Herpeticum, a severe, disseminated cutaneous HSV infection complicating atopic dermatitis.
- Co-infection with both HSV-1 and HSV-2 at the same anatomical site.
- Atypical cutaneous herpes simplex presentations in geriatric or pediatric populations.
- HSV-associated erythema multiforme triggers.
- Inconclusive clinical presentations of genital ulcer disease.
- Persistent HSV infection in immunocompromised hosts.
- Presence of viral DNA in amniotic fluid, indicating potential intrauterine transmission.
- Exclusion of HSV infection in patients with non-viral dermatological conditions.
Turnaround Time and Report Access at Chughtai Lab
Chughtai Lab is committed to delivering highly accurate diagnostic reports with optimal efficiency. Because the Herpes (HSV 1 & 2) PCR (Qualitative) is a sophisticated molecular test requiring DNA extraction, amplification, and detection phases, the standard turnaround time is typically 24 to 48 hours from the time of sample receipt at the molecular diagnostics laboratory.
To ensure maximum convenience for patients across Pakistan, Chughtai Lab offers multiple channels for report retrieval. Once the results are verified by a consultant pathologist, patients receive an automated SMS notification. Reports can be viewed, downloaded, and printed directly from the official Chughtai Lab website or via the dedicated Chughtai Lab mobile application. Physical reports can also be collected from any of the numerous Chughtai Lab collection centers nationwide.
Herpes (HSV 1 & 2) PCR (Qualitative) Findings Overview
The following table outlines the clinical interpretation of various parameters evaluated during the qualitative PCR analysis:
| Structure / Parameter Evaluated | Normal Findings | Possible Abnormal Findings |
|---|---|---|
| HSV-1 DNA (Lesion Swab) | Not Detected (Negative) | Detected (Positive) – Indicates active HSV-1 infection or viral shedding at the lesion site. |
| HSV-2 DNA (Lesion Swab) | Not Detected (Negative) | Detected (Positive) – Indicates active HSV-2 infection or viral shedding at the lesion site. |
| HSV-1/2 DNA (Cerebrospinal Fluid) | Not Detected (Negative) | Detected (Positive) – Indicates central nervous system infection (Encephalitis or Meningitis). |
| HSV-1/2 DNA (Whole Blood) | Not Detected (Negative) | Detected (Positive) – Indicates systemic viremia or disseminated herpes simplex infection. |
| HSV-1/2 DNA (Corneal Swab) | Not Detected (Negative) | Detected (Positive) – Indicates active ocular herpes simplex infection (Herpetic Keratitis). |
| Internal PCR Control | Detected (Valid Run) | Not Detected – Indicates PCR inhibition or technical failure; test must be repeated. |
| Specimen Adequacy | Sufficient cellular material | Inadequate sample – Insufficient cellular material collected; recollection is recommended. |
Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.
Why Choose Chughtai Lab for Herpes (HSV 1 & 2) PCR (Qualitative)?
- Experienced Healthcare Professionals: Our molecular biology department is staffed by highly trained scientists and led by experienced consultant pathologists.
- Advanced Molecular Technology: We utilize state-of-the-art real-time PCR platforms to ensure maximum sensitivity and specificity in viral detection.
- ISO 15189 Certified Quality: Chughtai Lab maintains international quality standards, ensuring rigorous quality control at every stage of testing.
- Convenient Home Sample Collection: Patients can request professional home sample collection services across major cities in Pakistan.
- Seamless Digital Access: Access your diagnostic reports securely online through our website or user-friendly mobile application.
- Extensive Nationwide Network: With hundreds of collection centers across Pakistan, our services are easily accessible.
- Temperature-Controlled Logistics: We employ strict cold-chain management to transport molecular samples, preserving viral DNA integrity.
- Patient-Focused Care: We prioritize patient comfort, privacy, and clinical confidentiality throughout the diagnostic process.